Bavar­i­an Nordic's mpox vac­cine was safe and spurred promis­ing im­mune re­sponse in chil­dren

Bavar­i­an Nordic’s mpox vac­cine Jyn­neos gen­er­at­ed a sim­i­lar im­mune re­sponse in ado­les­cents as it did in adults, of­fer­ing en­cour­ag­ing re­sults that sug­gest the shot would …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER